chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bell's palsy symptoms within an hour after receiving vaccine injection:  consisted of right-sided facial numbness, right-sided eyelid droop, right-sided mouth turn, right-sided tightness in neck muscle, pressure behind right eye, headache, loss of balance, difficulty speaking.  The injection was at 3:15 pm and started with arm soreness and stinging, a slight headache, and some tingling in my right hand while waiting 15 minutes after the shot, I had also felt a sensation going up the right side of the back of my neck almost immediately after the injection.  The Bell's palsy symptoms started by 4:00 pm.  I had a low-grade temp that evening of 99.9.  I emailed my neurologist who I see for migraines, of my symptoms.  The following morning on 03-10-2021 I woke with a severe migraine, fullness in my right ear, more pressure behind my right eye and it is watery, with new ringing in both ears, louder in the right ear.   Still residual numbness and drooping of right side of face and eye, tightness in right side neck muscle in front, and speaking better.   Woke up on Thursday morning 03-11-2021 with flu symptoms and migraine gone.  Eye pressure still there and now having significant pain moving my eye and now more feeling of fullness in my right ear.  Eye pain was concerning.  Dr advised me at this time if symptoms have continued or gotten worse to go to the emergency room.   Today, Saturday 03-13-2021, I am still experiencing moderate eye pain behind/above my right eye with pressure.  I am continuing to treat the pain with oxycodone prescribed by ER Physician.
Progress Notes Cosign Needed Expand All Collapse All     1/14/2021    Date:  1/14/2021                                                                                               Subjective 49 y.o. female who was seen at COVID Vaccine Clinic today for her first dose of the COVID 19 vaccination.    She denied any history of previous adverse reactions to vaccines.   She was given the Moderna vaccination in the left deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience headache.  She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to abdominal pain, blood pressure abnormality , chest pain, collapse, drooling, hypotension, increased swelling, rapid progression of symptoms, respiratory distress with none, skin changes, tongue swelling and vomiting.   Headache:  Bilateral across the forehead; 7/10, dull and pressure, similar to a migraine which she has not had for a while.  She usually treats it with Excedrin Migraine.  She did not eat breakfast today and was heading to work before this happened.     ALLERGY REVIEW OF SYSTEMS   Previous Reactions: none reported    Objective    Vitals Vitals:   01/14/21 0839 01/14/21 0853 BP: 129/78 (!) 140/84 BP Location:   Right arm Patient Position:   Sitting Cuff Size:   Large Adult Pulse: 85 84 SpO2: 96% 96%     Physical Exam Vitals signs reviewed.  Constitutional:      Appearance: She is obese.  HENT:     Head: Normocephalic.     Nose: Nose normal.  Eyes:     Pupils: Pupils are equal, round, and reactive to light.  Neck:     Musculoskeletal: Normal range of motion.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Pulses: Normal pulses.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds.  Musculoskeletal: Normal range of motion.  Skin:    General: Skin is warm and dry.  Neurological:     General: No focal deficit present.     Mental Status: She is alert and oriented to person, place, and time.  Psychiatric:        Mood and Affect: Mood normal.        Behavior: Behavior normal.        Thought Content: Thought content normal.        Judgment: Judgment normal.         Assessment/Plan  Treatment included: peanut butter, water, crackers. Follow up response to treatment: good.  Headache unchanged. Patient discharge: Stable to go home and follow up with PCP.           1/14/2021 9:05 AM
This spontaneous report as received from a registered nurse refers to an unknown number of patients of unknown age and gender. Relevant medical history and concomitant medication were not provided. On 22-OCT-2013 the patients were vaccinated with M-M-R II. Dose, route and frequency were not provided. On 22-OCT-2013, the patients were vaccinated with M-M-R II stored as high as 47F for up to 44 hours. No adverse effects were reported. This case was linked to MARRS case numbers 1311USA008054, 1311USA007705, 1311USA007695, 1311USA007696, 1311USA007699, 1311USA007700, 1311USA007701, 1311USA007702, 1311USA007703, 1311USA007698, 1311USA007697, 1311USA008057, 1311USA008058, 1311USA008059, 1311USA008060, 1311USA008055, 1311USA000906, 1311USA008061, 1311USA008056 (same reporter link). Additional information has been requested.
Patient states she noticed a pain while throwing a rock in her shoulder, the same side as her 1st COVID vaccine, about a week before her 2nd dose. Reports she has full ROM without pain pain now and has not had pain since she threw the rock. She did not seek medical care and denies any other s/s.
After injection patient experienced a racing heart and felt like she would faint. After 30 minutes she was fine and left.
Sore arm,  body/muscle pains, diarrhea, mild nausea. Had confirmed COVID-19 in Oct 2020 (positive PCR test and positive antibodies confirmed), and the vaccine side effects are far worse than the original illness, which produced only loss of taste and smell.
he has a congested cough that has increased recently; nausea; fatigue/ still very tired; He had chills; fever/ mild temperature; This is a spontaneous report from two contactable consumers (patient's wife and patient himself). An 83-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: EK4176, expiry date Jul2022) via an unspecified route of administration in arm right, at the age of 83-year-old, on 26Jan2021 12:00PM, SINGLE DOSE for covid-19 immunisation.  Medical history included ongoing chronic obstructive pulmonary disease (for 15 years or more), ongoing spinal stenosis in his lower back for about 15 years or more, and rotator cuff syndrome (left arm). Concomitant medication included ongoing sertraline hydrochloride (ZOLOFT). The patient did not receive other vaccines within 4 weeks. The patient experienced nausea on 28Jan2021 with outcome of not recovered, fever/ mild temperature on Jan2021 with outcome of not recovered, fatigue/ still very tired on 28Jan2021 with outcome of not recovered, he had chills on 28Jan2021 with outcome of not recovered, he has a congested cough that has increased recently on Feb2021 with outcome of not recovered. The patient went to his eye doctor for an eye exam, and he was not real comfortable because he was semi-nauseous. The patient had experienced fatigue, tiredness, and nausea since receiving his first COVID-19 Vaccine dose. The patient reported he also had chills. The patient had an increase in a congested cough recently. The patient continues to feel fatigued, tired, and nauseated. The patient felt like he should have gone to the Emergency Room, or seen his doctor when he experienced the side effects after the vaccine, but he didn't go. The patient has been taking cough medicine. The patient has COPD  and takes the cough medicine at night before he goes to bed. The patient clarified that he started taking the cough medicine because he had an increase in a congested cough recently. The patient clarified he has a sticky, yellowish phlegm that he coughs up. The patient said recently the phlegm changed to a reddish-brown color. The patient said his phlegm will go back and forth from the yellowish color to a dark brown color. The patient said he started the cough medicine about a week or so ago. The patient said it was a 4 ounce bottle of cough medicine. The patient said he takes a 20ml dose at night, so he doesn't start hacking while he sleeps. The patient just finished the 4 ounce bottle of cough medicine last night. The patient takes over-the-counter Tussin DM Max cough medicine. The patient is scheduled for his second COVID-19 Vaccine on 15Feb2021.
9MAY97 c/o feet hurting-balls of feet & heels burning & arches painful that got worse over next 2 days;saw MD on 12MAY w/c/o inc pain feet could hardly walk-achy all over;BP 114/92;dx synovitis;14MAY97 c/o joint pain,tired;
Per telephone conversation with patient father he states that his daughter vomiting early this morning. Returned to school the following day.
Information has been received on 15-FEB-2019 regarding a case in litigation concerning a 77 year old male patient. The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In 2015, the patient was administered the ZOSTAVAX vaccine (lot# and route not specified) by a pharmacist. In 2016, the patient was treated by a physician for shingles as a result of vaccination with ZOSTAVAX. The outcome was not provided. Additional information has been requested.
Patient reported chills and slight pain at injection site on 12/4/17 and then next day had signs and symptoms of skin infection on arm but not at injection site. Arm was red, warm, tender, swollen on inside of right arm above elbow and around bicep.
2 hives that are red and warm to touch; Fatigue; Hives near throat; Swollen throat; Itchy Legs; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm), FATIGUE (Fatigue), URTICARIA (Hives near throat), OROPHARYNGEAL PAIN (Swollen throat) and PRURITUS (Itchy Legs) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm). On 16-Feb-2021, the patient experienced FATIGUE (Fatigue), URTICARIA (Hives near throat), OROPHARYNGEAL PAIN (Swollen throat) and PRURITUS (Itchy Legs). On 17-Feb-2021, the patient experienced URTICARIA (2 hives that are red and warm to touch). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 16-Feb-2021, PAIN IN EXTREMITY (Soreness in arm), FATIGUE (Fatigue), URTICARIA (Hives near throat), OROPHARYNGEAL PAIN (Swollen throat) and PRURITUS (Itchy Legs) had resolved. At the time of the report, URTICARIA (2 hives that are red and warm to touch) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
1-2 minutes after vaccine patient felt dizzy than blacked out. Lasted 1-2 minutes. No other SX at this time.
8/18/21: immediately after injection (5:00pm) - dizziness, nausea, racing heart, heart rate fluctuating from really high (120bpm) to low (50-60bpm) for about 15min, muscle pain in shoulders  8/18/21: (8:00pm) - arm pain and soreness 8/19/21: (7:00am) - arm pain and soreness 8/19/21: (10:00am) - tiredness, achy 8/19/21: (12:30pm) - extremely achy, extreme muscle pain in lower back and legs, nausea, headache 8/19/21: (3:00pm-6:00pm) - achy, muscle pain, fever, headache, tiredness
Slight fever - 99.6 w/onset 30NOV chills x 7 day. Diarrhea; weakness; pain in chest. MD visit on 4DEC90. no dx made.
This spontaneous report as received from a technologist (other health care professional) refers to unknown number of patients of unknown age. On an unknown date the unknown number of patients were vaccinated with VARIVAX (Dose: 0.5 milliliter (ml)), subcutaneous. The reporting technologist reported on an unknown date the unknown number of patients received VARIVAX that had multiple excursions. No adverse effects were reported. Additional information has been requested.
Following vax 62 yo male c/o weakness & difficulty swallowing&talking came to ER-hospitalized for 8 days Developed quadriplegia & resp difficulty,15Nov resp arrest. preliminary DX was Guillian Barre Synd.Final DX: GBS & resp failure
Rash over most of the body, started 2 days after vaccination.  To date used 2.5% cortisone cream to relieve itching.
Within seconds after receiving GARDASIL vaccination pt. slumped over against nurse head to (R) et chin to chest. Within 15 sec. he aroused, very pale et c/o dizziness. No n/v. Supportive care given, drank water. Remained seated x 20'. Left with mom. Color improved, denied dizziness. Call to mom next day - doing well.
4 days later tested positive for covid; This is a spontaneous report received from a contactable pharmacist. A 52-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on 23Jul2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient received the 1st dose of the vaccine and 4 days later on an unspecified date tested positive for covid. As per pharmacist, the patient has completed quarantine, and was asymptomatic. Reporter had concern, can the patient receive the second dose of the vaccine and wanted to know packaging sealed and intact. Vaccination of people with known current SARS-CoV-2 infection should be deferred until the person has recovered from the acute illness (if the person had symptoms) and they had met criteria to discontinue isolation. This recommendation applied to people who experience SARS-CoV-2 infection before receiving any vaccine dose and those who experience SARS-CoV-2 infection after the first dose of an mRNA vaccine but before receipt of the second dose. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on unknown date. The outcome of the events was reported as unknown.  Description of complaint: Pharmacist calling since there was a patient that received the covid vaccine first dose and four days later tested positive for covid. Asking if the patient should receive the second dose. He declined to complete report. He does not have lot number to provide.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Information has been received on 11-DEC-2018 from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In JANUARY 2017, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In JANUARY 2017, the patient was treated by a healthcare provider at a hospital for shingles. The patient was diagnosed with shingles and or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (not further specified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Dtap 12/13/06 Left arm. Swelling of Left arm started 12/14.  Seizure on 12/14/06.
Diffuse maculopapular pruritic rash started 3 days after vaccination. Given 8mg IM dexamethasone, and Prednisone tapered dose for 7 days on 7/13/21. Returned on 7/19/21 with worsening symptoms, visual blurring, and incontinence.
The site of the vaccine is red and very hard, warm to the touch, very fussy. Given TYLENOL and children's BENADRYL.
pressure; pain; soreness; weakness; headache; nausea; fever; chills; sweats; arm pain; felt like she was in a vice grip; This case was reported by a consumer via call center representative and described the occurrence of back pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included fibromyalgia, arthritis and gastric disorder.   On 5th July 2019, the patient received the 1st dose of Shingrix 50 µg. In July 2019, 12 hrs after receiving Shingrix, the patient experienced back pain, hip discomfort, joint pain, weakness, headache, nausea, fever, chills, sweating, pain in arm and feeling abnormal. On an unknown date, the outcome of the back pain, hip discomfort, joint pain, weakness, headache, nausea, fever, chills, sweating and pain in arm were recovering/resolving and the outcome of the feeling abnormal was unknown.   It was unknown if the reporter considered the back pain, hip discomfort, joint pain, weakness, headache, nausea, fever, chills, sweating, pain in arm and feeling abnormal to be related to Shingrix.  Additional information received were as follows: At noon, the patient received Shingrix on left arm. By midnight, the patient was having lower back and hip pressure, that felt like she was in a vice grip. The patient also noted joint pain in her elbow, knees, fingers and feet.  The patient had headache, nausea, chills and fever, along with weakness that kept her in bed till Monday. The patient noted all were still present but improving at the reporting date. The patient called the physician office and was told by the nurse to call back if symptoms worsened. The patient stated that she also reported it back to the pharmacy where she received the vaccine. The patient noted it was like affecting her in her weak spots, meaning she had a history of arthritis and fibromyalgia. Less than a week after receiving Shingrix, the patient also noted arm soreness.  The reporter consented to follow up. There was discrepancy between the outcome reported in the structured field (recovering/resolving) and the outcome reported in the source document (fatal). Retained as per the structural field of system.
No adverse event; 1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042J21A, 939902 and 053c21a) for COVID-19 prophylaxis.     No Medical History information was reported.   On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On 15-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021).    No concomitant medication was reported.  No treatment medication was reported.  Patients had been administered with the 3 Moderna vaccines which were beyond the 30 day beyond use date.  For lot 053C21A (dose 1)was 01-Jul-2021, for lot 939902 (dose 2) was 02-Sep-2021 and for lot 042J21A (dose 3)was 17-Feb-2022.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up received: Narrative was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:case
Feelings of dizziness and vertigo that started  2 weeks after the second shot and has continued for 2 weeks .
Patient experienced rapid heart palpitations and difficulty breathing but shortly after she was able to breath. pharmacist called the ambulance , when paramedics came , they checked the patient vitals . her heart beat and blood pressure was slightly high but vitals came down after 15 minutes and when they checked her vitals for the third time. vitals were in normal ranges. patient was asked if she wants to go to the hospital but she refused . paramedics left after patient claimed that she is feeling okay. Minutes after paramedics left patient started to have a rapid heart beat again.so pharmacist called the ambulance for the second time and when they came patient was taking to the hospital.
First pregnancy, was 25 weeks pregnant at time of first vaccination, EDD 8/27/2021. Still currently pregnant. When I took my glucose tolerance test (three days later) I had an abnormally elevated result. I have zero risk factors for gestational diabetes, no family history of GD, my first trimester HgA1C was 4.9.  Started checking blood sugars about a week after vaccination four times a day (fasting and one hour after each meal). In the first three days I had a few slightly elevated values. After that my blood sugars were all in the normal range. I was not diagnosed with gestational diabetes.
short time p/receiving vax pt felt tightness on lt side of body esp lt thigh became a tight knot then involved the entire thigh also lt side of neck became stiff & sore; cont into evening-call MD @ 8PM did not believe it was due to shot;
Minutes after HPV and hepatitis vaccines were given, my son's eyes rolled back in his head he fell off exam table and right side of his body was shaking as well as his head. I yelled for nurse. He came to quickly and they had him relax, drink Sprite and then he seemed ok but a little weak.